Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-004195·Candel Therapeutics, Inc.
Schedule 13G ownership disclosure
Candel Therapeutics Inc
Common Stock, $0.01 par value per share · CUSIP: 137404109
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Northpond Ventures, LP
Shares: 0.00 · Class: 0.0%
- Northpond Ventures GP, LLC
Shares: 0.00 · Class: 0.0%
- Northpond Ventures II, LP
Shares: 0.00 · Class: 0.0%
- Northpond Ventures II GP, LLC
Shares: 0.00 · Class: 0.0%
- Michael P. Rubin
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-004195
- Form type
- SCHEDULE 13G/A
- Filer
- Candel Therapeutics, Inc.
- CIK
- CIK 1841387
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership